Anna Jeong

699 total citations
22 papers, 346 citations indexed

About

Anna Jeong is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Anna Jeong has authored 22 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Physiology. Recurrent topics in Anna Jeong's work include Tuberous Sclerosis Complex Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neonatal and fetal brain pathology (3 papers). Anna Jeong is often cited by papers focused on Tuberous Sclerosis Complex Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neonatal and fetal brain pathology (3 papers). Anna Jeong collaborates with scholars based in United States, South Korea and Australia. Anna Jeong's co-authors include Michael Wong, Denise M. Oleske, David D. Limbrick, Mary Bertrand, Jo Anne Nakagawa, Irene Litvan, Ananth K. Vellimana, Thomas Kimber, Matthew D. Smyth and Meredith Spindler and has published in prestigious journals such as Neurology, The Lancet Neurology and International Journal of Molecular Sciences.

In The Last Decade

Anna Jeong

18 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Jeong United States 12 112 73 66 60 58 22 346
Eleonora Mauri Italy 7 80 0.7× 84 1.2× 83 1.3× 76 1.3× 50 0.9× 22 332
Daphne M. Hasbani United States 9 49 0.4× 82 1.1× 104 1.6× 85 1.4× 51 0.9× 13 314
Amina Gargouri Tunisia 10 138 1.2× 44 0.6× 37 0.6× 36 0.6× 29 0.5× 70 284
Qi‐Lun Lai China 11 162 1.4× 52 0.7× 24 0.4× 62 1.0× 21 0.4× 37 295
Mustafa Kömür Türkiye 11 109 1.0× 119 1.6× 20 0.3× 30 0.5× 45 0.8× 49 376
Fafa Tian China 11 90 0.8× 34 0.5× 54 0.8× 85 1.4× 81 1.4× 27 332
Ye Tu China 12 40 0.4× 25 0.3× 36 0.5× 29 0.5× 52 0.9× 35 290
Carolina Ferreira‐Atuesta United States 3 57 0.5× 74 1.0× 15 0.2× 31 0.5× 34 0.6× 7 204
Lawrence Samkoff United States 11 134 1.2× 47 0.6× 43 0.7× 59 1.0× 96 1.7× 30 456

Countries citing papers authored by Anna Jeong

Since Specialization
Citations

This map shows the geographic impact of Anna Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jeong more than expected).

Fields of papers citing papers by Anna Jeong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jeong. The network helps show where Anna Jeong may publish in the future.

Co-authorship network of co-authors of Anna Jeong

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Jeong. A scholar is included among the top collaborators of Anna Jeong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Jeong. Anna Jeong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Yi Rang, Anna Jeong, Suneel Gupta, et al.. (2025). Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals. Clinical Parkinsonism & Related Disorders. 13. 100359–100359.
2.
Choe, Nakwon, Anna Jeong, Hosouk Joung, et al.. (2025). Circular RNA circAtxn10 regulates skeletal muscle cell differentiation by targeting miR-143-3p and Chrna1. Korean Journal of Physiology and Pharmacology. 29(5). 637–648.
3.
Kwon, Duk‐Hwa, Sera Shin, Nakwon Choe, et al.. (2024). CBL-b E3 ligase-mediated neddylation and activation of PARP-1 induce vascular calcification. Experimental & Molecular Medicine. 56(10). 2246–2259. 2 indexed citations
5.
Fung, Victor S.C., Filip Bergquist, Maurizio Facheris, et al.. (2024). Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Motor Fluctuations in Parkinson’s Disease (P9-3.008). Neurology. 102(7_supplement_1). 1 indexed citations
6.
Kern, Drew S., Khashayar Dashtipour, Jason Aldred, et al.. (2023). Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial (S32.004). Neurology. 100(17_supplement_2).
7.
Cho, Yong‐Yeon, et al.. (2023). A Phase 1 First-in-human Study to Investigate the Safety, Tolerability and Food Effect of ABBV-CLS-7262 (P6-4.002). Neurology. 100(17_supplement_2). 2 indexed citations
8.
Soileau, Michael J., Jason Aldred, Nahome Fisseha, et al.. (2022). Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. The Lancet Neurology. 21(12). 1099–1109. 93 indexed citations
9.
Song, Sooyeon, et al.. (2022). Lactiplantibacillus plantarum L67 probiotics vs paraprobiotics for reducing pro‐inflammatory responses in colitis mice. International Journal of Dairy Technology. 76(1). 168–177. 18 indexed citations
10.
Oleske, Denise M., Xianbin Cheng, Anna Jeong, & Thomas J. Arndt. (2021). Pediatric Acute Ischemic Stroke by Age-Group: A Systematic Review and Meta-Analysis of Published Studies and Hospitalization Records. Neuroepidemiology. 55(5). 331–341. 21 indexed citations
11.
Kwon, Duk‐Hwa, Hosouk Joung, Jiyoung Kim, et al.. (2021). SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation. Experimental & Molecular Medicine. 53(2). 250–263. 11 indexed citations
12.
Jeong, Anna, Duk‐Hwa Kwon, Young‐Kook Kim, et al.. (2021). P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation. International Journal of Molecular Sciences. 22(18). 9944–9944. 13 indexed citations
13.
Jeong, Anna, et al.. (2019). Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature. Journal of Child Neurology. 34(12). 705–712. 50 indexed citations
14.
Gorman, Kathleen M., Anna Jeong, & Andrea C. Pardo. (2017). Neonatal SIRPIDs, a Confusing EEG Finding. Pediatric Neurology. 81. 45–46.
15.
Jeong, Anna, Jo Anne Nakagawa, & Michael Wong. (2017). Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex. Journal of Child Neurology. 32(14). 1092–1098. 25 indexed citations
16.
Jeong, Anna & Michael Wong. (2017). Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development. Journal of Child Neurology. 33(1). 55–63. 12 indexed citations
17.
Dlouhy, Brian J., Brandon A. Miller, Anna Jeong, et al.. (2016). Palliative epilepsy surgery in Dravet syndrome—case series and review of the literature. Child s Nervous System. 32(9). 1703–1708. 20 indexed citations
18.
Jeong, Anna & Michael Wong. (2016). mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology. Current Neurology and Neuroscience Reports. 16(12). 102–102. 18 indexed citations
19.
Jeong, Anna & Michael Wong. (2016). Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy. Expert Review of Neurotherapeutics. 16(4). 437–447. 8 indexed citations
20.
Jeong, Anna, Jennifer M. Strahle, Ananth K. Vellimana, et al.. (2016). Hemispherotomy in children with electrical status epilepticus of sleep. Journal of Neurosurgery Pediatrics. 19(1). 56–62. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026